Candriam S.C.A. Bio N Tech Se Put Options Transaction History
Candriam S.C.A.
- $17.1 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BNTX
# of Institutions
356Shares Held
38.4MCall Options Held
2.12MPut Options Held
2.17M-
Baillie Gifford & CO8.31MShares$860 Million0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$468 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$451 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$196 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$187 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25.1B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...